ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
22,88
-0,54
(-2,31%)
Fermé 20 Novembre 5:30PM

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

Dernier
22,88
Prix Achat
22,52
Prix Vente
22,92
Volume échangé
1 435 091
22,52 Fourchette du Jour 23,56
20,16 Plage de 52 semaines 27,44
Cap du marché
Clôture Veille
23,42
Ouverture
23,42
Dernière Transaction
400
@
22.88
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
564 241
Actions en circulation
138 385 510
Rendement du Dividende
4.37%
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-
Chiffre d'affairess
1,04B
Bénéfice net
434,57M

À propos de Azimut Hldg SPA

Secteur
Security Brokers & Dealers
Industrie
Security Brokers & Dealers
Site Web
Siège social
Milan, Lombardy, Ita
Fondé
-
Azimut Hldg SPA est coté dans le secteur Security Brokers & Dealers de la Italian Stock Exchange avec le ticker AZM. Le dernier cours de clôture d'Azimut Hldg était de 23,42 €. Au cours de la dernière année, les actions de Azimut Hldg ont été négociées dans une fourchette de prix de 20,16 € à 27,44 €.

Azimut Hldg compte actuellement 138 385 510 actions en circulation. La capitalisation boursière d'Azimut Hldg est de 3,24 € milliard.

AZM Dernières nouvelles

Alizyme Press Release

RNS Number:4707U HG Capital Trust PLC 21 January 2004 The following is the text of a press release issued by HgCapital, manager of the investment portfolio of HgCapital Trust plc...

Holding(s) in Company

RNS Number:1794U Alizyme PLC 13 January 2004 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Alizyme plc 2. Name of shareholder having a major...

Files New Patient Application

RNS Number:0774U Alizyme PLC 12 January 2004 FOR IMMEDIATE RELEASE 12 January 2004 ALIZYME FILES NEW PATENT APPLICATION FOR RENZAPRIDE Cambridge UK, 12 January 2004:...

Completion of Clinical Trial

RNS Number:0770U Alizyme PLC 12 January 2004 FOR IMMEDIATE RELEASE 12 January 2004 ALIZYME SUCCESSFULLY COMPLETES CLINICAL TRIAL FOR RENZAPRIDE IN IRRITABLE BOWEL SYNDROME PATIENTS IN...

Holding(s) in Company

RNS Number:6633T Alizyme PLC 24 December 2003 SCHEDULE 10 NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Name of company Alizyme plc 2. Name of shareholder having a major...

Phase IIa Clinical Trial

RNS Number:4599T Alizyme PLC 19 December 2003 For Immediate Release 19 December 2003 ALIZYME GRANTED CTX FOR PHASE IIa CLINICAL TRIAL FOR ATL-104 FOR MUCOSITIS Cambridge UK, 19...

Blocklisting Interim Review

RNS Number:8723R Alizyme PLC 10 November 2003 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Alizyme plc 2. Name of scheme Alizyme plc Share Option Scheme...

Director Shareholding

RNS Number:3073R Alizyme PLC 24 October 2003 For Immediate Release 24 October 2003 ALIZYME PLC DIRECTOR SHARE PURCHASE Alizyme plc (the "Company") received notification...

Institutional Placing

RNS Number:1606R Alizyme PLC 22 October 2003 Immediate Release 22 October 2003 ALIZYME PLC Institutional Placing Raises #11.5 million Alizyme Plc ("Alizyme" or "the...

Granted USA Patent

RNS Number:7020Q Alizyme PLC 09 October 2003 Immediate Release 9 October 2003 ALIZYME ANNOUNCES GRANT OF USA PATENT FOR ATL-962 FOR THE TREATMENT OF OBESITY AND RELATED DISORDERS...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.17-0.73752711496723.0523.5722.5266684823.16126226DE
4-1.21-5.0228310502324.0924.1922.3370054923.08940294DE
120.632.8314606741622.2524.4921.5556424122.93530498DE
26-2.61-10.239309533225.4925.4920.1653364622.94772102DE
520.914.1420118343221.9727.4420.1662381224.002073DE
156-3.67-13.822975517926.5527.4413.8164287621.56551444DE
2600.261.1494252873622.6227.4410.26592464719.75941179DE

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
1SMCISuper Micro Computer Inc
26,00 €
(30,92%)
37,28k
WGML25GM Leather spa
0,0139 €
(26,36%)
10k
WSOGESWarr Soges Group
0,04 €
(25,00%)
7,28k
SIFSif Italia Spa
1,48 €
(19,35%)
26,5k
LASIASIA
2,62 €
(13,91%)
59,5k
1NKLANikola Corp
1,85 €
(-30,04%)
36,72k
WUBM26Ulisse BioMed SpA
0,137 €
(-21,71%)
2k
WLDB24Lindbergh Spa
0,46 €
(-18,71%)
53,01k
1SPCEVirgin Galactic Holdings Inc
6,40 €
(-17,95%)
650
WSGC28SG Company SpA
0,025 €
(-16,11%)
7,54k
TITTelecom Italia SpA
0,2299 €
(-3,77%)
217,58M
ISPIntesa Sanpaolo Spa
3,708 €
(-1,28%)
92,7M
SPMSaipem Spa
2,33 €
(-1,60%)
34,03M
ENELEnel Spa
6,635 €
(-0,96%)
30,67M
TITRTelecom Italia
0,2728 €
(-3,67%)
27,56M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock